SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Praxis Precision Medicines announces Nasdaq Rule 5635(c)(4) inducement grants

Praxis Precision Medicines said its Board Compensation Committee approved inducement grants under Nasdaq Listing Rule 5635(c)(4) on September 1, 2026.

PRAX

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories